OPK
HEALTHCAREOpko Health Inc
$1.12-0.01 (-0.88%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving OPK Today?
No stock-specific AI insight has been generated for OPK yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.98$1.60
$1.12
Fundamentals
Market Cap$846M
P/E Ratio—
EPS$-0.27
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.4%
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding755.1M
OPK News
20 articles- OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater ChinaYahoo Finance·Apr 30, 2026
- BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital PlatformYahoo Finance·Apr 30, 2026
- OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/YYahoo Finance·Apr 29, 2026
- OPKO Health Inc (OPK) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...Yahoo Finance·Apr 29, 2026
- OPKO Health Q1 Earnings Call HighlightsMarketbeat·Apr 28, 2026
- OPKO Health (OPK) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·Apr 28, 2026
- OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesYahoo Finance·Apr 28, 2026
- OPKO Health Reports First Quarter 2026 Business Highlights and Financial ResultsYahoo Finance·Apr 28, 2026
- How The OPKO Health (OPK) Narrative Is Shifting After Mixed Results And A Lower Price TargetYahoo Finance·Apr 23, 2026
- Here's Why You Should Hold OPK Stock in Your Portfolio for NowYahoo Finance·Apr 23, 2026
- OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell LymphomasYahoo Finance·Apr 22, 2026
- OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026Yahoo Finance·Apr 21, 2026
- OPKO Health, Inc. (OPK) Makes Progress on Game changing Covid-19 TreatmentYahoo Finance·Apr 14, 2026
- OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19Yahoo Finance·Apr 8, 2026
- Entera Bio Announces Full Year 2025 Financial Results and Provides Business UpdatesYahoo Finance·Mar 27, 2026
- How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst SignalsYahoo Finance·Mar 27, 2026
- Barrington Lowers PT on OPKO Health (OPK), Keeps a BuyYahoo Finance·Mar 20, 2026
- OPK Q4 Earnings & Revenues Beat Estimates, Gross Margin ContractsYahoo Finance·Feb 27, 2026
- OPKO Health, Inc. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- OPKO Health Q4 Earnings Call HighlightsMarketbeat·Feb 27, 2026
All 20 articles loaded
Price Data
Open$1.14
Previous Close$1.13
Day High$1.14
Day Low$1.12
52 Week High$1.60
52 Week Low$0.98
52-Week Range
$0.98$1.60
$1.12
Fundamentals
Market Cap$846M
P/E Ratio—
EPS$-0.27
Dividend Yield—
Dividend / Share—
ROE-0.2%
Profit Margin-0.4%
Debt / Equity—
Trading
Volume1.7M
Avg Volume (10D)—
Shares Outstanding755.1M
About Opko Health Inc
OPKO Health, Inc., a healthcare company, is engaged in the pharmaceutical and diagnostic businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company is headquartered in Miami, Florida.
HEALTHCAREDIAGNOSTICS & RESEARCH
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDIAGNOSTICS & RESEARCH
CIK—
Composite FIGI—
Share Class FIGI—